Molecular Diagnostics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Molecular Diagnostics Market to 2027 - Global Analysis and Forecasts by Product (Reagents & Kits, Instruments, Services & Software), Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), In Situ Hybridization, DNA Microarray, and Others), Application (Infectious Diseases, Oncology, Genetic Tests, and Others) End User (Hospital & Academic Laboratories, Reference Laboratories, and Others), and Geography

Report Code: TIPRE00003124 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Molecular diagnostics includes various techniques to analyze biological markers in the genome and proteome. These techniques are used to guide patient's right from diagnosis to treatment, for diseases like cancer, infectious disease, and congenital abnormalities. These techniques help in identifying the genetic variants that have led to the disease. Molecular diagnostic procedures that are routinely used include polymerase chain reaction (PCR), real-time PCR, restriction fragment length polymorphism analysis (RFLP), fluorescence in situ hybridization, gel electrophoresis, single-stranded conformation polymorphism, hybrid capture, and other assays.

The molecular diagnostics market is anticipated to grow in the forecast period owing to key factors such as increasing prevalence of infectious diseases and different types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market and advancements in molecular techniques. However, technical issues related to sample collection and storage and risk of contamination and complex regulatory scenario hampers growth of this market.

The "Global Molecular Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global molecular diagnostics market with detailed market segmentation by product, technology, application, end user and geography. The global molecular diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading molecular diagnostics market players and offers key trends and opportunities in the market.

The global molecular diagnostics market is segmented on the basis of product, technology, application, and end user. Based on product, the molecular diagnostics market is segmented as reagents & kits, instruments, software and services. Based on technology, the molecular diagnostics market is segmented polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing & next-generation sequencing (NGS), in situ hybridization, DNA microarray, other technologies. On the basis of application the molecular diagnostics market is segmented as infectious diseases, oncology, genetic tests, other. The end user segment consists of hospital & academic laboratories reference laboratories and other.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Molecular diagnostics market based on product, technology application and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The molecular diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the molecular diagnostics market in the forecast period, due to growing prevalence of infectious diseases and cancers, presence of large number of well-established market players in the U.S., sophisticated healthcare structure and growing aging population are likely to influence the growth of the molecular diagnostics market. However, Asia Pacific region is expected to be the fastest growing region owing to increasing prevalence of chronic diseases and growing focus on development of better diagnostic procedures.

The report analyzes factors affecting molecular diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the molecular diagnostics market in these regions.

The report also includes the profiles of key molecular diagnostics companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the molecular diagnostics market include, Abbott, Agilent Technologies, Inc, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN, bioMérieux SA, BD, Illumina, Inc., and Danaher among others.




TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Molecular Diagnostics Market- By Product
1.3.2. Molecular Diagnostics Market- By Technology
1.3.3. Molecular Diagnostics Market- By End User
1.3.4. Molecular Diagnostics Market- By Region
1.3.4.1. By Country

2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. MOLECULAR DIAGNOSTICS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MOLECULAR DIAGNOSTICS MARKET- GLOBAL ANALYSIS
6.1. MOLECULAR DIAGNOSTICS MARKET - GLOBAL MARKET OVERVIEW
6.2. MOLECULAR DIAGNOSTICS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. REAGENTS & KITS MARKET
7.3.1. Overview
7.3.2. Reagents & Kits Market Forecast and Analysis (US$ Mn)
7.4. SOFTWARE AND SERVICES MARKET
7.4.1. Overview
7.4.2. Software and Services Market Forecast and Analysis (US$ Mn)
7.5. INSTRUMENTS MARKET
7.5.1. Overview
7.5.2. Instruments Market Forecast and Analysis (US$ Mn)

8. MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. POLYMERASE CHAIN REACTION MARKET
8.3.1. Overview
8.3.2. Polymerase Chain Reaction Market Forecast and Analysis (US$ Mn)
8.4. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET
8.4.1. Overview
8.4.2. Isothermal Nucleic Acid Amplification Technology Market Forecast and Analysis (US$ Mn)
8.5. DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS) MARKET
8.5.1. Overview
8.5.2. DNA Sequencing & Next-Generation Sequencing (NGS) Market Forecast and Analysis (US$ Mn)
8.6. IN SITU HYBRIDIZATION MARKET
8.6.1. Overview
8.6.2. in Situ Hybridization Market Forecast and Analysis (US$ Mn)
8.7. DNA MICROARRAY MARKET
8.7.1. Overview
8.7.2. DNA Microarray Market Forecast and Analysis (US$ Mn)
8.8. OTHERS MARKET
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis (US$ Mn)
9. MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. INFECTIOUS DISEASES MARKET
9.3.1. Overview
9.3.2. Infectious Diseases Market Forecast and Analysis (US$ Mn)
9.4. ONCOLOGY MARKET
9.4.1. Overview
9.4.2. Oncology Market Forecast and Analysis (US$ Mn)
9.5. GENETIC TESTS MARKET
9.5.1. Overview
9.5.2. Genetic Tests Market Forecast and Analysis (US$ Mn)
9.6. OTHERS MARKET
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis (US$ Mn)

10. MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS & ACADEMIC LABORATORIES MARKET
10.3.1. Overview
10.3.2. Hospitals & Academic Laboratories Market Forecast and Analysis (US$ Mn)
10.4. REFERENCE LABORATORIES MARKET
10.4.1. Overview
10.4.2. Reference Laboratories Market Forecast and Analysis (US$ Mn)
10.5. OTHERS MARKET
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis (US$ Mn)

11. MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET
11.1.1. North America Molecular Diagnostics Market Forecasts and Analysis (US$ Mn)
11.1.2. North America Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.1.3. North America Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.4. North America Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.1.5. North America Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.1.6. North America Molecular Diagnostics Market Forecasts and Analysis - By Country
11.1.7. US Market Overview
11.1.7.1. US Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.1.7.2. US Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.7.3. US Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.1.7.4. US Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.1.8. Canada Market Overview
11.1.8.1. Canada Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.1.8.2. Canada Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.8.3. Canada Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.1.8.4. Canada Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.1.9. Mexico Market Overview
11.1.9.1. Mexico Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.1.9.2. Mexico Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.1.9.3. Mexico Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.1.9.4. Mexico Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2. EUROPE MOLECULAR DIAGNOSTICS MARKET
11.2.1. Europe Molecular Diagnostics Market Forecasts and Analysis (US$ Mn)
11.2.2. Europe Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.2.3. Europe Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.4. Europe Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.2.5. Europe Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2.6. Europe Molecular Diagnostics Market Forecasts and Analysis - By Country
11.2.7. UK Market Overview
11.2.7.1. UK Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.2.7.2. UK Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.7.3. UK Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.2.7.4. UK Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2.8. Germany Market Overview
11.2.8.1. Germany Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.2.8.2. Germany Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.8.3. Germany Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.2.8.4. Germany Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2.9. France Market Overview
11.2.9.1. France Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.2.9.2. France Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.9.3. France Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.2.9.4. France Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2.10. Italy Market Overview
11.2.10.1. Italy Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.2.10.2. Italy Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.10.3. Italy Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.2.10.4. Italy Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.2.11. Spain Market Overview
11.2.11.1. Spain Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.2.11.2. Spain Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.2.11.3. Spain Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.2.11.4. Spain Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET
11.3.1. Asia Pacific Molecular Diagnostics Market Forecasts and Analysis (US$ Mn)
11.3.2. Asia Pacific Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.3.3. Asia Pacific Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.4. Asia Pacific Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.3.5. Asia Pacific Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3.6. Asia Pacific Molecular Diagnostics Market Forecasts and Analysis - By Country
11.3.7. China Market Overview
11.3.7.1. China Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.3.7.2. China Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.7.3. China Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.3.7.4. China Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3.8. Japan Market Overview
11.3.8.1. Japan Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.3.8.2. Japan Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.8.3. Japan Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.3.8.4. Japan Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3.9. India Market Overview
11.3.9.1. India Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.3.9.2. India Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.9.3. India Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.3.9.4. India Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3.10. South Korea Market Overview
11.3.10.1. South Korea Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.3.10.2. South Korea Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.10.3. South Korea Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.3.10.4. South Korea Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.3.11. Australia Market Overview
11.3.11.1. Australia Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.3.11.2. Australia Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.3.11.3. Australia Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.3.11.4. Australia Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.4. MIDDLE EAST AND AFRICA (MEA) MOLECULAR DIAGNOSTICS MARKET
11.4.1. Middle East and Africa (MEA) Molecular Diagnostics Market Forecasts and Analysis (US$ Mn)
11.4.2. Middle East and Africa (MEA) Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.4.3. Middle East and Africa Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.4. Middle East and Africa (MEA) Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.4.5. Middle East and Africa (MEA) Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.4.6. Middle East and Africa (MEA) Molecular Diagnostics Market Forecasts and Analysis - By Country
11.4.7. UAE Market Overview
11.4.7.1. UAE Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.4.7.2. UAE Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.7.3. UAE Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.4.7.4. UAE Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.4.8. Saudi Arabia Market Overview
11.4.8.1. Saudi Arabia Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.4.8.2. Saudi Arabia Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.8.3. Saudi Arabia Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.4.8.4. Saudi Arabia Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.4.9. South Africa Market Overview
11.4.9.1. South Africa Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.4.9.2. South Africa Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.4.9.3. South Africa Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.4.9.4. South Africa Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.5. SOUTH AND CENTRAL AMERICA MOLECULAR DIAGNOSTICS MARKET
11.5.1. South and Central America Molecular Diagnostics Market Forecasts and Analysis (US$ Mn)
11.5.2. South and Central America Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.5.3. South and Central America Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.5.4. South and Central America Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.5.5. South and Central America Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.5.6. South and Central America Molecular Diagnostics Market Forecasts and Analysis - By Country
11.5.7. Brazil Market Overview
11.5.7.1. Brazil Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.5.7.2. Brazil Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.5.7.3. Brazil Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.5.7.4. Brazil Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
11.5.8. Argentina Market Overview
11.5.8.1. Argentina Molecular Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
11.5.8.2. Argentina Molecular Diagnostics Market Forecasts and Analysis - By Technology (US$ Mn)
11.5.8.3. Argentina Molecular Diagnostics Market Forecasts and Analysis - By Applications (US$ Mn)
11.5.8.4. Argentina Molecular Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
12. INDUSTRY LANDSCAPE
12.1. ORGANIC GROWTH STRATEGIES
12.1.1. New Product Launches
12.1.2. Marketing & Promotional Activities
12.2. INORGANIC GROWTH STRATEGIES
12.2.1. Partnerships, Collaborations, and Joint Ventures
12.2.2. Mergers & Acquisitions

13. MOLECULAR DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1. THERMO FISHER SCIENTIFIC INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AGILENT TECHNOLOGIES, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ABBOTT
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. QIAGEN
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BD
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. F. HOFFMANN-LA ROCHE LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ILLUMINA, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. DANAHER
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIOMÉRIEUX SA
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BIO-RAD LABORATORIES, INC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Agilent Technologies, Inc.
3. Thermo Fisher Scientific Inc.
4. F. Hoffmann-La Roche Ltd.
5. Bio-Rad Laboratories, Inc.
6. QIAGEN
7. bioMérieux SA
8. BD
9. Illumina, Inc.
10. Danaher
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book